Wells Fargo’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-84,506
Closed -$509K 6794
2019
Q4
$509K Sell
84,506
-10,895
-11% -$65.6K ﹤0.01% 4251
2019
Q3
$343K Buy
95,401
+15,621
+20% +$56.2K ﹤0.01% 4487
2019
Q2
$214K Sell
79,780
-20,766
-21% -$55.7K ﹤0.01% 4765
2019
Q1
$298K Buy
100,546
+4,581
+5% +$13.6K ﹤0.01% 4563
2018
Q4
$152K Sell
95,965
-5,479
-5% -$8.68K ﹤0.01% 4874
2018
Q3
$373K Sell
101,444
-17,667
-15% -$65K ﹤0.01% 4509
2018
Q2
$337K Buy
119,111
+1,969
+2% +$5.57K ﹤0.01% 4596
2018
Q1
$435K Sell
117,142
-14,052
-11% -$52.2K ﹤0.01% 4381
2017
Q4
$378K Sell
131,194
-65,344
-33% -$188K ﹤0.01% 4463
2017
Q3
$882K Sell
196,538
-23,109
-11% -$104K ﹤0.01% 3871
2017
Q2
$1.01M Buy
219,647
+3,827
+2% +$17.6K ﹤0.01% 3655
2017
Q1
$908K Buy
215,820
+22,931
+12% +$96.5K ﹤0.01% 3756
2016
Q4
$797K Buy
192,889
+44,209
+30% +$183K ﹤0.01% 3785
2016
Q3
$1.2M Sell
148,680
-15,334
-9% -$124K ﹤0.01% 3299
2016
Q2
$1.28M Sell
164,014
-19,781
-11% -$154K ﹤0.01% 3253
2016
Q1
$1.42M Sell
183,795
-51,054
-22% -$394K ﹤0.01% 3126
2015
Q4
$2.53M Sell
234,849
-14,881
-6% -$161K ﹤0.01% 2780
2015
Q3
$1.73M Sell
249,730
-35,664
-12% -$246K ﹤0.01% 3051
2015
Q2
$2.53M Sell
285,394
-2,554,546
-90% -$22.6M ﹤0.01% 2893
2015
Q1
$28M Buy
2,839,940
+2,505,796
+750% +$24.7M 0.01% 1116
2014
Q4
$4.09M Buy
334,144
+64,541
+24% +$791K ﹤0.01% 2478
2014
Q3
$2.69M Buy
269,603
+11,791
+5% +$118K ﹤0.01% 2796
2014
Q2
$1.95M Buy
257,812
+18,463
+8% +$140K ﹤0.01% 2995
2014
Q1
$787K Buy
239,349
+224,332
+1,494% +$738K ﹤0.01% 3595
2013
Q4
$50K Sell
15,017
-1,534,969
-99% -$5.11M ﹤0.01% 4663
2013
Q3
$4.68M Sell
1,549,986
-843,151
-35% -$2.55M ﹤0.01% 2237
2013
Q2
$19.6M Buy
+2,393,137
New +$19.6M 0.01% 1163